Detalhe da pesquisa
1.
Recurrent moderate-risk mutations in Finnish breast and ovarian cancer patients.
Int J Cancer
; 145(10): 2692-2700, 2019 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30927251
2.
Exome Sequencing of Uterine Leiomyosarcomas Identifies Frequent Mutations in TP53, ATRX, and MED12.
PLoS Genet
; 12(2): e1005850, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26891131
3.
Somatic MED12 Nonsense Mutation Escapes mRNA Decay and Reveals a Motif Required for Nuclear Entry.
Hum Mutat
; 38(3): 269-274, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28054750
4.
Breast-cancer risk in families with mutations in PALB2.
N Engl J Med
; 371(6): 497-506, 2014 Aug 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-25099575
5.
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.
J Med Genet
; 53(12): 800-811, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27595995
6.
Somatic MED12 mutations in prostate cancer and uterine leiomyomas promote tumorigenesis through distinct mechanisms.
Prostate
; 76(1): 22-31, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26383637
7.
MED12 mutations and FH inactivation are mutually exclusive in uterine leiomyomas.
Br J Cancer
; 114(12): 1405-11, 2016 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-27187686
8.
Evaluation of the RHINO gene for breast cancer predisposition in Finnish breast cancer families.
Breast Cancer Res Treat
; 144(2): 437-41, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24562772
9.
Germline variation in TP53 regulatory network genes associates with breast cancer survival and treatment outcome.
Int J Cancer
; 132(9): 2044-55, 2013 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23034890
10.
RAD51C is a susceptibility gene for ovarian cancer.
Hum Mol Genet
; 20(16): 3278-88, 2011 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21616938
11.
Eukaryotic translation initiation factor 4E (eIF4E) expression is associated with breast cancer tumor phenotype and predicts survival after anthracycline chemotherapy treatment.
Breast Cancer Res Treat
; 141(1): 79-88, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23974830
12.
Multi-variant pathway association analysis reveals the importance of genetic determinants of estrogen metabolism in breast and endometrial cancer susceptibility.
PLoS Genet
; 6(7): e1001012, 2010 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20617168
13.
7q21-rs6964587 and breast cancer risk: an extended case-control study by the Breast Cancer Association Consortium.
J Med Genet
; 48(10): 698-702, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21931171
14.
Genome-wide association study for ovarian cancer susceptibility using pooled DNA.
Twin Res Hum Genet
; 15(5): 615-623, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22794196
15.
A novel uterine leiomyoma subtype exhibits NRF2 activation and mutations in genes associated with neddylation of the Cullin 3-RING E3 ligase.
Oncogenesis
; 11(1): 52, 2022 Sep 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36068196
16.
Variants on the promoter region of PTEN affect breast cancer progression and patient survival.
Breast Cancer Res
; 13(6): R130, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-22171747
17.
Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer.
Breast Cancer Res
; 13(1): R10, 2011 Jan 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-21269472
18.
Association of ESR1 gene tagging SNPs with breast cancer risk.
Hum Mol Genet
; 18(6): 1131-9, 2009 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19126777
19.
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers.
Hum Mol Genet
; 18(22): 4442-56, 2009 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19656774
20.
Glycodelin expression associates with differential tumour phenotype and outcome in sporadic and familial non-BRCA1/2 breast cancer patients.
Breast Cancer Res Treat
; 128(1): 85-95, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20676758